According to the latest grading criteria, meningiomas should be classified as WHO grade 3 whenever telomerase reverse transcriptase (TERT) promoter mutations and/or cyclin-dependent kinase inhibitor 2 A/B(CDKN2A/B) pure deletions are present (5). The gene discussed is CDKN2A; the disease is meningioma.